2026 Annual Meeting | C170 - Neurological Complications of Medical and Surgical Therapies

Date Wednesday 04/22/26

Time 07:00 AM - 09:00 AM CDT Add To Calendar

Location McCormick Place West | W180

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Charles Kassardjian, MD, F�鶹��ýӳ��

Topic(s) General Neurology

Learning Objectives Participants should be able to describe the the components of post-intensive care unit syndrome; recognize the complications of ICU care; identify common and serious neurological complications in transplant patients; recognize the serious and common side effects of immunotherapy, especially glucocorticoids; and recent literature on management.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:40 AM CDT	Speaker	Complications (and Prevention) of Immunotherapies Charles Kassardjian, MD, F�鶹��ýӳ��
07:40 AM - 08:20 AM CDT	Speaker	Neurologic Complications of Transplant Care and Treatment Alexandra Muccilli, MD
08:20 AM - 09:00 AM CDT	Speaker	Neurologic Complications of Critical Care Maximiliano A. Hawkes, MD

Faculty Disclosures
Charles Kassardjian, MD, F�鶹��ýӳ��	Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme.
Alexandra Muccilli, MD	Dr. Muccilli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Muccilli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Muccilli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Muccilli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Maximiliano A. Hawkes, MD	Dr. Hawkes has or had stock in Navinetics-AI.